Skip to main content
An official website of the United States government

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Altshuler, Rachel, Ph.D.
rachel.altshuler@nih.gov
240-276-5873
5E304 Program Officer | Breast and Gynecologic Cancer
Asefa, Mela
mela.asefa@nih.gov
240-276-6422
5E328 Program Support Assistant | Breast and Gynecologic Cancer
Program Support Assistant | Prostate and Urologic Cancer
Brofsky, Emma, M.S.P.H.
emma.brofsky@nih.gov
240-276-7532
5E314 Program Analyst | Breast and Gynecologic Cancer
Dimond, Eileen, R.N., M.S.
eileen.dimond@nih.gov
240-276-7086
5E332 Nurse Consultant | Breast and Gynecologic Cancer
Frech, Maria Silvina, Ph.D., M.S.
maria.frech@nih.gov
240-276-5302
5E320 Program Officer | Breast and Gynecologic Cancer
Heckman-Stoddard, Brandy, Ph.D., M.P.H.
brandy.heckman-stoddard@nih.gov
240-276-7048
5E334 Chief | Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials
Perloff, Marjorie, M.D.
marjorie.perloff@nih.gov
240-276-7097
5E544 Program Officer | Breast and Gynecologic Cancer
Rubinstein, Wendy, M.D., Ph.D.
wendy.rubinstein@nih.gov
5E436 Program Officer | Breast and Gynecologic Cancer
Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H.
vikrant.sahasrabuddhe@nih.gov
240-276-7332
5E444 Deputy Chief | Breast and Gynecologic Cancer
Samimi, Goli, Ph.D., M.P.H.
goli.samimi@nih.gov
240-276-6582
5E336 Program Officer | Breast and Gynecologic Cancer
Sauter, Edward, M.D., Ph.D.
edward.sauter@nih.gov
240-276-7657
5E338 Program Officer | Breast and Gynecologic Cancer
Streck, Brennan, Ph.D., RN, M.P.H.
brennan.streck@nih.gov
240-276-7050
5E430 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
White, Vanessa A., M.P.H.
vanessa.white@nih.gov
240-276-6163
5E524 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
Wood (Gunn), Kristen, B.S.N.
kristen.gunn@nih.gov
5E326 Nurse Consultant | Breast and Gynecologic Cancer

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 5U01CA214263-07 Matthew Young, Ph.D.
Shah, Sohrab P

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 5R01CA281928-03 Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter

University Of California, San Francisco
United States

Pre-cancer atlas of skin cancer 4U01CA294536-02 Nicholas Hodges, Ph.D.
Shalon, Tidhar Dari

Envivo Bio Inc
United States

Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring 5R33CA260665-04 Amit Kumar, Ph.D.
Shelby, Rebecca A

Duke University
United States

Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05 Brennan Streck, Ph.D., RN, M.P.H.
Shiozawa, Yusuke

Wake Forest University Health Sciences
United States

Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 1R21CA297068-01 Rachel Altshuler, Ph.D.
Shirwan, Haval

University Of Missouri-Columbia
United States

Developing a novel agonist of CD137 for cancer immunoprevention 5UG3CA290305-02 Altaf Mohammed, Ph.D.
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Shureiqi, Imad

University Of Michigan At Ann Arbor
United States

ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism 5R01CA266223-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad

Commonspirit Health Research Institute
United States

CIRI Oncology Research Alliance 3UG1CA189809-11S1 Vanessa A. White, M.P.H.
Sidransky, David

Johns Hopkins University
United States

Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 5R01CA265975-04 Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C

University Of Iowa
United States

Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers 5R01CA267820-03 Nicholas Hodges, Ph.D.
Sigel, Keith Magnus

Icahn School Of Medicine At Mount Sinai
United States

The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors 4R01CA256660-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M

University Of California, San Diego
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 5U01CA282272-03 Matthew Young, Ph.D.